There is no IP here people. The IP was created in this CHAT room. It is a potential drug like thousands of other ones out there. However, this one failed a Phase II and a phase III
Exactly. The same goes for exosomes. I believe it was immediately after Sunrise was stopped at the first look in that PPHM management trotted out exosomes,but as usual for them there was no data from pre-clinical studies , no projected timeline for starting human trials and no explanation of the risks and competition. It was merely an attempt to deflect from the dramatic failure that was Sunrise.
Market Data 
Markets 
AI
